CSL shares have seen a significant downturn due to recent challenges, yet analysts see potential for recovery, with a projected rebound to $275, driven by its strong foundation and global healthcare ...

CSL shares remain down 35.2% over the past year, impacted by concerns over vaccine sales and strategic changes. Analyst John Athanasiou from Red Leaf Securities suggests CSL shares are oversold, ...

Forget one of one: this particular BMW 3.0 CSL is, quite literally, the very first M race car, and it’s up for sale for presumably many dollars. The very first official BMW M project was the 3.0 CSL.

Our fair value estimate is 30% higher than CSL's analyst price target of US$248 In this article we are going to estimate the intrinsic value of CSL Limited (ASX:CSL) by projecting its future cash ...

Another day, another PS5 game leaked before its official announcement. This time around, the sequel to an underrated cooperative third-person shooter that has yet to be revealed has received a rating ...

Sony has rolled out another firmware update for a PS5 accessory, this time, for the Pulse Elite headset. This is the third accessory firmware update this week, and although patch notes have not been ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...

SYDNEY—Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its staff.

Coming from one of the biggest names in sim racing hardware, the Fanatec Gran Turismo DD Pro bundle should be a go-to for those looking to make the jump from controller to wheel. After all, Fanatec ...

Australian biotechnology firm CSL Ltd (OTCQX:CSLLY) (OTCQX:CMXHF) is set to downsize its research and development (R&D) division across six international sites, and increase its reliance on external ...

CSL is consolidating its R&D team in an effort to better position the organization “for long-term success in a rapidly evolving global environment.” The Australia-based biopharma and manufacturer is ...

Dave Ross - Senior Vice President and General Manager, CSL Seqirus Hervé Gisserot - Senior Vice President and General Manager, CSL Vifor Thank you for standing by and welcome to the CSL Limited Half ...